Monday, August 31, 2015 Last update: 6:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Conversant Bio Publishes Guide to Multiple Myeloma

Companies mentioned in this article: Conversant Bio

HUNTSVILLE, AL -- (Marketwired) -- 05/20/14 -- Conversant Bio, a global leader in supplying the highest-quality human tissue and viable cell samples, today announced it is publishing a guide about multiple myeloma. The e-book, Researcher's Guide to Multiple Myeloma: From the Real World to the Lab, is available as a free download at: http://www.conversantbio.com/multiple-myeloma-ebook

Multiple myeloma is a hematologic cancer that develops in the marrow of the long bones. Researchers are working toward a cure, and this new e-book provides them with a basic foundation of how the disease is approached in the real world. Features of the guide include:

  • How multiple myeloma is diagnosed
  • The different types of multiple myeloma
  • Labwork results of typical multiple myeloma patients in different stages
  • Treatments and side effects

Furthermore, the e-book also details the challenges faced when studying multiple myeloma, including obtaining quality bone marrow and blood samples that are integral for research.

"Researchers will benefit from this e-book when they are developing the criteria and parameters of their multiple myeloma research," says Luke Doiron, Chief Commercial Officer of Conversant Bio. "They will gain a new perspective on the disease that is outside the scope of the lab. And if they are in need of high-quality bone marrow and blood samples for their research, they can achieve access to such samples through Conversant Bio"

To download Researcher's Guide to Multiple Myeloma: From the Real World to the Lab, visit http://www.conversantbio.com/multiple-myeloma-ebook.

About Conversant Bio
Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting-edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S.-based clinical sites and an IRB-reviewed chain of custody quality control system, Conversant Bio provides the highest-quality samples on time and on budget. For additional information about Conversant Bio's services, visit the company's website at http://www.conversantbio.com.

Contact: